CASI PHARMACEUTICALS, INC. Accumulated Other Comprehensive Income
CASI PHARMACEUTICALS, INC. had Accumulated Other Comprehensive Income of -$703.00 thousand as of 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2023-04-26
- 2022-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$703.00K.
- 2022-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.95M.
- 2022-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$160.00K.
- 2022-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $2.13M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2022-12-31 | -$703.00K 20-F · filed 2023-04-26 | |
| 2022-09-30 | -$1.95M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$160.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.13M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $1.95M 20-F · filed 2023-04-26 | |
| 2021-09-30 | $1.17M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $1.16M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $485.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $589.00K 10-K · filed 2022-03-28 | |
| 2020-09-30 | -$1.51M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$3.89M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$3.55M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$2.73M 10-K · filed 2021-03-30 | |
| 2019-09-30 | -$3.86M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | -$2.03M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | -$914.53K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$1.23M 10-K · filed 2020-03-16 | -$1.23M 10-K · filed 2019-03-29 |
| 2018-09-30 | -$1.22M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$539.64K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $527.25K 10-Q · filed 2018-05-15 | |
| 2018-01-01 | $1.20M 10-K · filed 2019-03-29 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-29 |